- West Virginia University School of Medicine
- Hematology / Oncology
- MD, University of Pittsburgh, 2010
Ross K, Gillespie-Twardy AL, Agha M, Raptis A, Hou JZ, Farah R, Redner RL, Im A, Duggal S, Ding F, Lin Y, Boyiadzis M. Intensive chemotherapy in patients aged 70 years or older newly diagnosed with acute myeloid leukemia. Oncol Res 2015;22(2):85-92.
Gutman J, Ross KG, Smith C, Myint H, Lee, C-K, Salit R, Milano F, Delaney C, Gao D, Pollyea DA. Chronic GVHD Burden and Late Transplant Complications Are Lower Following Adult Cord Blood versus MURD Transplant. Bone Marrow Transplant 2016 Dec;51(12):1588-1593.
Ross KG, Gutman JA. Conditioning regimens for cord blood transplants. In Cord Blood Transplant. (2017)
Submitted for Publication
Fei N, Shah N, Cumpston A, Wen S, Ross KG, Craig M, Kanate A. Low-dose acyclovir prophylaxis for varicella zoster reactivation in autologous hematopoietic cell transplantation recipients. Submitted to Transplant Infectious Disease (2017).
Awards and Honors:
2001-2005 Ben Franklin Scholar (University of Pennsylvania Honor Program)
2004-2005 Dean’s List, University of Pennsylvania
2003-2005 Delta Phi Alpha German Honor Society
2005 Graduated Cum Laude
2005-2006 Fulbright Scholarship to Germany
2007 T-35 NIH Grant for research in Hematology/Oncology
Professional Committees and Scientific Societies:
2006-2010 American Medical Student Association
2006-2010 American Medical Association
2006-2013 Pennsylvania Medical Society
2006-2013 Allegheny County Medical Society
2009-2010 American College of Physicians
2014-2016 American Society of Clinical Oncology
2013-present American Society of Hematology
2015-present American Society of Bone Marrow Transplant
About Kelly Ross
Dr. Kelly Ross completed her Bachelor of Arts degree in Biology from the University of Pennsylvania in Philadelphia, Pennsylvania (2005) and MD from the University Of Pittsburgh School of Medicine in Pittsburgh, Pennsylvania (2010). She completed her residency in Internal Medicine at the University of Pittsburgh Medical Center in Pittsburgh, Pennsylvania (2013), Hematology/Oncology Fellowship (2015) and her Bone Marrow Transplant Fellowship at the University of Colorado in Denver, Colorado (2016).
During her academic career, Dr. Ross received several prestigious awards, including a Fulbright Scholarship. She is a member of the American Society of Hematology, American Society of Bone Marrow Transplantation and the West Virginia Oncology Society. She is Board certified in Internal Medicine, Hematology, and Oncology, and currently serves as chair of the Transfusion Committee at WVU as well as serving on the Promotion and Tenure Committee. She has several published and submitted publications.
Dr. Ross joined the Hematology/Oncology Section at West Virginia University as an Assistant Professor in the Osborn Hematopoietic Malignancy and Transplantation Program (WVU Cancer Institute) in 2016. Her particular areas of interest include acute myeloid leukemia and umbilical cord blood transplant.
She speaks English and German and was a member of the Colorado Symphony Orchestra Chorus prior to coming to WVU.
Grants and Research
Grants and Contracts:
2007 T-35 NIH Grant, Hematology/Oncology Research Assistant under Anthony Brickner, PhD, $3,500.
2003-2004 Research Assistant, Mentor: Nancy Cooke, MD in the Endocrine/Genetics Department at the University of Pennsylvania
2005 Investigating the role of HIV-1 vpr (viral protein R) on cellular expression of lipodystrophy-associated genes using real-time PCR. Mentor: Velpandi Ayyavoo, PhD, Department of Infectious Diseases and Microbiology, University of Pittsburgh.
2007 Research Assistant, Mentor: Anthony Brickner, PhD, Department of Hematology/Oncology at the UPMC Hillman Cancer Center
2008-2009 Reviewing the incidence of awareness in the Department of Anesthesiology, University of Pittsburgh Medical Center, between 01/00 and 12/08. Mentor: Ibtesam Hilmi, MB CHB, FRCA.
2011-2012 Evaluating outcomes of induction chemotherapy for acute myeloid leukemia in patients over age 70, between 2000-2011. Mentor: Dr. Michael Boyiadzis
2013-2016 Writing and organizing a phase I investigator-initiated clinical trial for relapsed AML using cyclophosphamide and arsenic. Comparing rates of GVHD and infection in matched unrelated donor versus dual umbilical cord blood bone marrow transplant. Mentor: Dr. Jonathan Gutman
- Acute Myeloid Leukemia
- Umbilical cord blood transplant
- Graft versus host disease
Patient Care Information
- Cancer / Oncology
- Hematological Malignancies and Stem Cell Transplant
- Hematology/Oncology (Cancer)
- Medical Oncology (Cancer)
- Internal Medicine, American Board of Internal Medicine
Fellowship, Bone Marrow Transplant Fellowship
University of Colorado Hospital, 2016
University of Colorado Hospital, 2015
Residency, Internal Medicine
University of Pittsburgh Medical Center, 2013